2020 On-site Forms Industry and Scientific Advisory Board
2020 On-site has formed an Industry and Scientific Advisory Board (IASAB) that will steer its initiatives by gathering insights, sharing ideas, and debating critical business concepts.
The board’s seven members will gather quarterly to identify patient needs, product opportunities and market challenges associated with the provision of vision-related assessments for clinical trials and safety surveillance programs.
On the board are Ms. Jeanne Taylor Hecht, IASAB chair and the founder and CEO of JTH Consulting, LLC; Rajat Agrawal MD, MS, CEO and president of Retina Global; Jeffrey S. Heier, MD, director of the vitreoretinal service and retina research at Ophthalmic Consultants of Boston; Peter K. Kaiser, MD, Chaney Family Endowed Chair in Ophthalmology Research and a professor of ophthalmology at the Cleveland Clinic Lerner College of Medicine; Beth Marsh, vice president of North America Sales and Marketing, Ophthalmology, for Apellis Pharmaceuticals; Jason Menzo, Chief Operating Officer of Foundation Fighting Blindness; and Adam Ramsey, OD, an optometrist and owner of Socialite Vision.
For more information, click here.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
